Finance

Beta
Lists
Q4 2026 earnings • released • EPS beat +0.56% • Revenue beat +2.02%
See results
2M6:ETR
Medtronic PLC
€70.66
+0.68%
(+0.48) 1D
Jun 5, 12:45:18 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 2M6...
Open
€71.04
High
€71.04
Low
€70.44
Mkt. cap
105.19B
Avg. vol.
2.56K
Volume
969.00
52-wk high
€91.50
52-wk low
€62.86
No. of employees
95K
Open
€71.04
High
€71.04
Low
€70.44
Mkt. cap
105.19B
Avg. vol.
2.56K
Volume
969.00
52-wk high
€91.50
52-wk low
€62.86
No. of employees
95K
News stories
From sources across the web
Profile
Medtronic plc is an American-Irish medical device company. The company's legal and executive headquarters are in Ireland, while its operational headquarters are in Minneapolis, Minnesota. Medtronic rebased to Ireland following its acquisition of Irish-based Covidien in 2015. While it primarily operates in the United States, it operates in more than 150 countries and employs over 90,000 people. It develops and manufactures healthcare technologies and therapies. It is one of the biggest medical tech companies in the world and is currently the largest medical device company in the world by revenue. The company has developed several world-first technologies since its inception, including wearable and implantable pacemakers, the implantable cardioverter-defibrillator, and remote patient monitoring systems. They also created miniaturized devices like the world's smallest pacemaker and spinal cord stimulator. Wikipedia
About Medtronic PLC
CEOGeoffrey S. Martha
Employees95K
Founded1949
Headquarters-
SectorMedical device
Websitemedtronic.com
Last report
Jun 3, 2026
Fiscal period
Q4 2026
EPS / Est. (USD)
$1.55 / $1.54
+0.56%beat
Revenue / Est. (USD)
9.81B / 9.61B
+2.02%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
8.58B
8.96B
9.02B
9.81B
Cost of goods sold
2.98B
3.06B
3.17B
-
Cost of revenue
2.98B
3.06B
3.17B
3.37B
Research and development expenses
726.00M
754.00M
722.00M
670.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.78B
2.94B
2.93B
2.96B
Operating expense
3.99B
4.08B
4.04B
4.42B
Total operating expenses
6.98B
7.14B
7.21B
7.79B
Operating income
1.60B
1.82B
1.80B
2.02B
Other non operating income
68.00M
3.00M
13.00M
68.00M
EBT including unusual items
1.30B
1.60B
1.40B
1.84B
EBT excluding unusual items
1.62B
1.68B
1.66B
1.73B
Income tax expense
255.00M
215.00M
254.00M
575.00M
Effective tax rate
19.59%
13.47%
18.10%
31.34%
Other operating expenses
72.00M
-29.00M
-79.00M
499.00M
Net income
1.04B
1.37B
1.14B
1.24B
Net profit margin
12.12%
15.33%
12.68%
12.68%
Earnings per share
1.26
1.36
1.36
1.55
Interest and investment income
120.00M
89.00M
102.00M
-
Interest expense
-176.00M
-181.00M
-181.00M
-486.00M
Net interest expenses
-56.00M
-92.00M
-79.00M
-486.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.31B
2.52B
2.52B
2.86B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer